Protecting innovation in bioinformatics and in-silico biology.
Commercial success or failure of innovation in bioinformatics and in-silico biology requires the appropriate use of legal tools for protecting and exploiting intellectual property. These tools include patents, copyrights, trademarks, design rights, and limiting information in the form of 'trade secrets'. Potentially patentable components of bioinformatics programmes include lines of code, algorithms, data content, data structure and user interfaces. In both the US and the European Union, copyright protection is granted for software as a literary work, and most other major industrial countries have adopted similar rules. Nonetheless, the grant of software patents remains controversial and is being challenged in some countries. Current debate extends to aspects such as whether patents can claim not only the apparatus and methods but also the data signals and/or products, such as a CD-ROM, on which the programme is stored. The patentability of substances discovered using in-silico methods is a separate debate that is unlikely to be resolved in the near future.
Harrison
Robert
R
Huber & Schüssler Intellectual Property Attorneys, Munich, Germany. rharrison@iprights.com
D019295:Computational Biology / Q000331:legislation & jurisprudence* / Q000639:trends; D003198:Computer Simulation / Q000331:legislation & jurisprudence* / Q000639:trends; D005062:European Union; D018973:Intellectual Property; D007391:International Cooperation; D008954:Models, Biological; D014481:United States